Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 49 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Transient lower esophageal sphincter relaxations: How many or how harmful?Sifrim, D.; Holloway, R.
2008The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illnessNguyen, Q.; Chapman, M.; Fraser, R.; Bryant, L.; Burgstad, C.; Ching, K.; Bellon, M.; Holloway, R.
2005Transient lower esophageal sphincter relaxations (TLESRs) are the major mechanism of gastroesophageal reflux but are not the cause of reflux diseaseIwakiri, K.; Hayashi, Y.; Kotoyori, M.; Tanaka, Y.; Kawakami, A.; Sakamoto, C.; Holloway, R.
2008Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intoleranceNguyen, Q.; Ching, K.; Fraser, R.; Chapman, M.; Holloway, R.
2008Diminished functional association between proximal and distal gastric motility in critically ill patientsNguyen, Q.; Fraser, R.; Bryant, L.; Chapman, M.; Holloway, R.
2007Prokinetic therapy with erythromycin has no significant impact on blood pressure and heart rate in critically ill patientsNguyen, Q.; Mangoni, A.; Fraser, R.; Chapman, M.; Bryant, L.; Burgstad, C.; Holloway, R.
2008The impact of delaying enteral feeding on gastric emptying plasma cholecystokinin and peptide YY concentrations in critically ill patientsNguyen, Q.; Fraser, R.; Bryant, L.; Burgstad, C.; Chapman, M.; Bellon, M.; Wishart, J.; Holloway, R.; Horowitz, M.
2000Treatment of gastro-oesophageal reflux disease through control of transient lower oesophageal sphincter relaxations - feasibility, practicality and possibilitiesHolloway, R.
2007Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illnessNguyen, Q.; Chapman, M.; Fraser, R.; Bryant, L.; Holloway, R.
2007Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrationsNguyen, Q.; Fraser, R.; Chapman, M.; Bryant, L.; Holloway, R.; Yandell, R.; Wishart, J.; Feinle-Bisset, C.; Horowitz, M.